Volume : 10, Issue : 09, September – 2023

Title:

47.ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF CITICOLINE AND PIRACETAM IN BULK AND TABLET DOSAGE FORM BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Authors :

Kanjarla Bhavani*, MRS. Bheemagoni Jyothi

Abstract :

Formulation and evaluation of floating tablets of Atenolol. In the present study the formulations were prepared by direct compression method using different proportions of HPMC K4M, HPMC K15M, and HPMC K100M as Swellable polymers. Sodium bicarbonate is used as buoyancy-imparting agent. The prepared formulations were evaluated for different parameters during its pre-compression and post-compression stages. The release characteristics of the formulations were studied in in-vitro conditions. The in-vitro dissolution study of formulation F8 was 99.41% within 12 h for good release and was fitted to kinetics of drug release for R2 value of Higuchi release mechanism model is 0.964. As an extension of this work for formulation F8, bioavailability, pharmacokinetic, and in-vivo studies can be done in future to develop as suitable candidate for a novel drug delivery system.
Key words: Atenolol, HPMC K4M, HPMC K15M, HPMC K100M and Floating Tablets.

Cite This Article:

Please cite this article in press Vankudavath Roja et al, Formulation And Invitro Evaluation Of Effervescent Floating Tablets Of Atenolol, Indo Am. J. P. Sci, 2023; 10 (09).

Number of Downloads : 10

References:

1. Pooja Gupta, Gnanarajan, Preeti Kothiyal. Floating Drug Delivery System: A Review. International Journal of Pharma Research & Review, August 2015; 4(8):37-44.
2. Shweta Arora, Floating drug delivery systems: A review AAPS Pharm SciTech.: E372–E390, Vol-6, Issue 3, September (2005).
3. GSN Koteswara Rao, KV Ramana Murthy, Aayisha Begum, B Roja Rani, Ch Ragha Naveen, B Raj Kumar, et al. Formulation and Evaluation of Floating Drug Delivery Systems of Propranolol HCl using Modified Pulsincap Technique. International Journal of Pharma Research & Review, Sept 2014; 3(9):15-22.
4. Avaru Geetha Dutt, Ande Pratyusha, Uma Maheshwar Rao, Motor Leela Keerthi, Kalakuntla Sai Krishna, Ashok Morsu. Formulation and Evaluation of Gastro Retentive Drug Delivery System of Tizanidine Hydrochloride: A Review. International Journal of Pharma Research & Review, Oct 2014; 3(10):34-45.
5. Hirtz J. The git absorption of drugs in man: review of current concepts and methods of investigation. Br J Clin Pharmacol. 1985; 19:77SY83S.
6. Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site specific delivery. Int J Pharm 1996; 136:117-139.
7. Gwen.M.jantezen, and Joseph.R.Robinson, Sustained and Controlled release drug delivery systems, Chapter-15, page 501-523.
8. Ponchel G, Irache JM. Specific and nonspecific bioadhesive particulate system for oral delivery to the gastrointestinal tract. Adv Drug Del Rev. 1998; 34:191Y219.
9. Lenaerts VM, Gurny R. Gastrointestinal TractPhysiological variables affecting the performance of oral sustained release dosage forms. In: Lenaerts V, Gurny R, eds. Bioadhesive Drug Delivery System. Boca Raton, FL: CRC Press; 1990.
10. Garg.R and Gupta.GD., Progress in controlled gastroretentive delivery systems, Trop J Pharma Res, September 2008; 7 (3): 1055-1066.
11. Jain Amit K, Hatila Umashankar. A Review On Floating Drug Delivery System. IJPSR/Vol. II/ Issue III/July-September, 2011/01-06.
12. Vantrappen GR, Peeters TL, Janssens J. The secretory component of interdigestive migratory motor complex in man. Scand J Gastroenterol. 1979;14:663-667.
13. Wilson CG, Washington N. The stomach: its role in oral drug delivery. In: Rubinstein MH, ed. Physiological Pharmacetical: Biological Barriers to Drug Absorption. Chichester, UK: Ellis Horwood; 1989:47-70.
14. Grubel P. et al, Gastric emptying of non-digestible solids in the fasted dog. J. Pharm. Sci. 1987, 76, 117 – 122.
15. Roop K. Khar, Controlled Drug Delivery, Gastroretentive system 4th edn.,; 202-203.
16. Khan F.N, Dehghan H.G., Int J Health Res 2009; 2(1): 23
17. Deshpande A.A, Shah N.H, Rhodes C.T, Malick W. Pharm Res 1997; 14: 815-819
18. Davis SS, Stockwell AF, Taylor MJ. Pharm Res 1986; 3: 208-213
19. Lehr CM. Crit Rev Ther Drug Carrier Syst 1994; 11: 119-160
20. Groning R, Heun G. Drug Dev Ind Pharm 1984; 10: 527-539